Scinai Immunotherapeutics Ltd. (SCNI)
Market Closed
16 Jun, 20:00
$
0. 35
-0.02
-4.6703%
$
435.39K Market Cap
- P/E Ratio
- Div Yield
727,289 Volume
- Eps
$ 0.36
Previous Close Want to track SCNI and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Scinai Immunotherapeutics Ltd. (SCNI) Statistics
Valuation metrics
Market Cap 435.39K
Enterprise value 817.39K
Trailing P/E (ttm) -0
Forward P/E -
PEG ratio 0
Price/Sales (ttm) 0.31
Price/Book (mrq) 0
Enterprise Value/Revenue 0.58
Enterprise Value/EBITDA -0.11
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 485.03K
Average volume (90 days) 3.39M
Price summary
52-Week low 0.3
52-Week high 3.48
Beta -
50-Day moving average 0.52
200-Day moving average 0.68
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:10
Last split Date 21 May 2024
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -1.89%
Operating margin -5.74%
Operational effectiveness
Return on assets -0.15%
Return on equity -0.3%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 1,494.87
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -2,823.36
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 3,289.58
Total debt (mrq) -
Total Debt/Equity (mrq) 0.3
Current ratio (mrq) 1.35%
Book value per share (mrq) 12,424.12
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
